These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33167239)

  • 21. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
    Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
    Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.
    White GW; Gibby WA; Tweedle MF
    Invest Radiol; 2006 Mar; 41(3):272-8. PubMed ID: 16481910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
    Runge VM
    J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination.
    Ruprecht N; Parakkattel D; Hofmann L; Broekmann P; Lüdi N; Kempf C; Heverhagen JT; von Tengg-Kobligk H
    Invest Radiol; 2024 May; 59(5):372-378. PubMed ID: 37824716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry.
    Telgmann L; Faber H; Jahn S; Melles D; Simon H; Sperling M; Karst U
    J Chromatogr A; 2012 Jun; 1240():147-55. PubMed ID: 22525874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry.
    Künnemeyer J; Terborg L; Nowak S; Brauckmann C; Telgmann L; Albert A; Tokmak F; Krämer BK; Günsel A; Wiesmüller GA; Karst U
    Electrophoresis; 2009 May; 30(10):1766-73. PubMed ID: 19441033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined speciation analysis and elemental bioimaging provide new insight into gadolinium retention in kidney.
    Bücker P; Funke SKI; Factor C; Rasschaert M; Robert P; Sperling M; Karst U
    Metallomics; 2022 Mar; 14(3):. PubMed ID: 35150284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
    Puttagunta NR; Gibby WA; Smith GT
    Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme.
    Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D
    J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.
    Lin J; Idee JM; Port M; Diai A; Berthommier C; Robert M; Raynal I; Devoldere L; Corot C
    J Pharm Biomed Anal; 1999 Dec; 21(5):931-43. PubMed ID: 10703961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild Dissolution/Recomplexation Strategy for Speciation Analysis of Gadolinium from MR Contrast Agents in Bone Tissues by Means of HPLC-ICP-MS.
    Schlatt L; Köhrer A; Factor C; Robert P; Rasschaert M; Sperling M; Karst U
    Anal Chem; 2021 Aug; 93(33):11398-11405. PubMed ID: 34387072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speciation of cisplatin in environmental water samples by hydrophilic interaction liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Vidmar J; Martinčič A; Milačič R; Ščančar J
    Talanta; 2015 Jun; 138():1-7. PubMed ID: 25863363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
    Telgmann L; Sperling M; Karst U
    Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TiO₂ nanoparticles functionalized monolithic capillary microextraction online coupled with inductively coupled plasma mass spectrometry for the analysis of Gd ion and Gd-based contrast agents in human urine.
    Liu X; Chen B; Zhang L; Song S; Cai Y; He M; Hu B
    Anal Chem; 2015 Sep; 87(17):8949-56. PubMed ID: 26239367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the MRI contrast agent Gd-DTPA by SEC-ICP-MS.
    Loreti V; Bettmer J
    Anal Bioanal Chem; 2004 Aug; 379(7-8):1050-4. PubMed ID: 15235758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clearance of gadolinium chelates by hemodialysis: an in vitro study.
    Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA
    J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.